Michael K. Templin

Director of Finance/CFO at

ABT Molecular Imaging, Inc.

Health Technology

Commercial Services

Consumer Services

Profile

Michael K.
Templin is currently the Chief Financial Officer & Vice President-Finance at ABT Molecular Imaging, Inc. He previously held the same position at CTI Molecular Imaging, Inc. and worked as an Audit Manager at Coopers & Lybrand LLP.
He received his undergraduate degree and MBA from the University of Tennessee.

Michael K. Templin active positions

Companies	Position	Start
ABT Molecular Imaging, Inc. ABT Molecular Imaging, Inc. BiotechnologyHealth Technology Develops a production platform to generate unit doses of molecular imaging drugs	Director of Finance/CFO	2013-01-31

All active positions of Michael K. Templin

Former positions of Michael K. Templin

Companies	Position	End
Coopers & Lybrand LLP Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services	Corporate Officer/Principal	-
CTI Molecular Imaging, Inc. CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology Makes positron emission tomography scanners	Director of Finance/CFO	-

See the detail of Michael K. Templin's experience

Training of Michael K. Templin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael K. Templin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
CTI Molecular Imaging, Inc. CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology Makes positron emission tomography scanners	Health Technology
Coopers & Lybrand LLP Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services	Commercial Services
University of Tennessee University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ABT Molecular Imaging, Inc. ABT Molecular Imaging, Inc. BiotechnologyHealth Technology Develops a production platform to generate unit doses of molecular imaging drugs	Health Technology